FDA Approval for Low-Grade Serous Ovarian Cancer: A New Era in Treatment Podcast By  cover art

FDA Approval for Low-Grade Serous Ovarian Cancer: A New Era in Treatment

FDA Approval for Low-Grade Serous Ovarian Cancer: A New Era in Treatment

Listen for free

View show details

About this listen

Discover a groundbreaking advancement in ovarian cancer care in this episode of Teal Talk – An Ovarian Cancer Podcast! Leading experts Dr. Deborah Richardson and Dr. Rachel Grisham join the discussion to explore the FDA approval of the first targeted treatment for recurrent low-grade serous ovarian cancer (LGSOC) with KRAS mutations. Whether you're a patient, caregiver, or healthcare provider, this episode offers vital insights into the future of ovarian cancer treatment.

💬 Like, comment, and subscribe for more vital discussions about ovarian cancer.

📋 Survey Link: https://bit.ly/tealtalksurvey

👉 For more information about ovarian cancer and the National Ovarian Cancer Coalition, visit https://ovarian.org.

This podcast is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always talk to a qualified healthcare provider if you have questions about your health. The podcast is created independently by the National Ovarian Cancer Coalition and is not influenced by sponsors or outside groups.

No reviews yet